Roger Hajjar

IDB Consulting SA develops and markets information technology solutions. The company offers database management, application development, data warehousing, software support, and business intelligence services. Additionally, IDB Consulting provides outsourced accounting, budgeting, forecasting, and financial consulting services to startups and small private companies. The company partners with Oracle Corporation and IBM. Its clientele includes Everest Group, HSBC, PriceWaterHouse, Banc of America, and Meriwest Credit Union. The company was founded in 1995 and is headquartered in Paris, France

Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.

GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France.

Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France.

Oger Investissements SAS operates as an investment holding company, with interests in the healthcare industry. The company is headquartered in Aix-en-Provence, France.

Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021.